## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and evidence as presented in the abstract; no access to full manuscript, figures, tables, or supplementary data
- **Shared manuscript claim summary** The authors report a yeast-two-hybrid (Y2H) screen identifying human C14orf166 fragments as interactors of influenza A virus PA protein. They generated three-dimensional models of PA and C14orf166 using I-TASSER, predicted interaction models with ClusPro, and analyzed them with PyMol. They conclude that the carboxy-terminal end of C14orf166 binds to the carboxy-terminal region of PA, with an intense interaction region at PA amino acids 610-630.
- **Visible evidence base** Abstract text only; no experimental details, structural validation metrics, docking scores, or statistical analyses are provided
- **Missing materials affecting confidence** Full manuscript, Y2H screening details, clone identities and fragment sizes, sequence alignments, model quality scores (e.g., C-score, TM-score), docking output parameters, validation of interaction interfaces, and any experimental confirmation of the predicted models

## Reviewer
- **Overall assessment** The abstract presents a plausible computational workflow combining Y2H screening with homology-based structural modeling and protein-protein docking. The biological premise is interesting, given the known role of C14orf166 in influenza A virus replication. However, the evidence provided in the abstract is insufficient to evaluate the technical rigor of the modeling and docking steps, the statistical significance of the Y2H results, or the reliability of the proposed interaction interface. The central claim regarding the PA 610-630 region as the intense interaction site is not supported by quantitative data in the supplied material.
- **Who would be interested in the results, and why** Researchers studying influenza A virus-host interactions, particularly those focused on the viral RNA polymerase complex and host factors that modulate replication. Structural biologists and computational biologists interested in protein-protein interaction prediction methods may also find the workflow relevant, though the lack of experimental validation limits broader appeal.
- **Major strengths** The study addresses a biologically relevant question with potential implications for understanding influenza virus replication. The combination of Y2H screening with computational modeling is a reasonable exploratory approach. The identification of a specific PA region (610-630) provides a testable hypothesis for future experimental work.
- **Major Concerns** 
  - R1-M1
  - R1-M2
  - R1-M3
- **Minor Comments** 
  - R1-m1
  - R1-m2
  - R1-m3
- **Technical failings that need to be addressed before the case is established** The abstract does not provide any model quality metrics for the I-TASSER predictions, any docking scores or cluster statistics from ClusPro, or any evidence that the predicted interface is statistically significant versus random docking poses. The Y2H results are described qualitatively without clone counts, reproducibility, or controls. Without these, the interaction model cannot be considered technically established.
- **Assessment against Nature-style criteria** 
  - Originality: Moderate. The application of Y2H plus docking to this specific host-virus pair is somewhat novel, but the methods are standard and the conceptual advance is limited.
  - Scientific importance: Moderate. The finding could inform influenza biology, but the abstract does not demonstrate functional significance of the predicted interface.
  - Interdisciplinary readership: Limited. The work sits at the intersection of virology and computational biology, but the lack of experimental validation narrows its appeal.
  - Technical soundness: Not assessable from the abstract. Critical details on model quality and docking reliability are absent.
  - Readability for nonspecialists: The abstract is generally clear, though terms like "tRNA-splicing ligase complex" and "nucleo-cytoplasmic transport" may require background knowledge. The logic from screening to modeling to conclusion is understandable.
- **Recommendation posture** Currently not established from the provided evidence. The abstract suggests a potentially interesting finding, but the technical basis for the central interaction model claim is not visible. A revised submission with full methodological detail and validation metrics would be required for a supportive posture.

### Major Concerns

- **Concern ID** R1-M1
- **Severity** Major
- **Blocking** Yes
- **Axis** Technical soundness of structural models
- **Claim pointer** The authors claim that three-dimensional structures of PA and C14orf166 were generated using I-TASSER and that interaction models were predicted with ClusPro.
- **Evidence pointer** Abstract, methods description; location not provided
- **Concern** The abstract provides no information on the quality of the I-TASSER models, such as C-scores, TM-scores, or template identities. Similarly, no ClusPro output parameters are given, including cluster sizes, weighted scores, or the number of models per cluster. Without these metrics, the reliability of the predicted structures and docking poses cannot be assessed.
- **Why it matters** Low-quality homology models can produce misleading docking results. If the PA or C14orf166 models are inaccurate, the predicted interaction interface, including the claimed 610-630 region, may be an artifact of the modeling process rather than a biologically meaningful feature.
- **Resolution test** Provide model quality scores for both I-TASSER predictions, list the templates used and their sequence identities, and report ClusPro cluster statistics with the top-ranked model's score. Show that the predicted interface is consistent across multiple docking runs or with alternative algorithms.

- **Concern ID** R1-M2
- **Severity** Major
- **Blocking** Yes
- **Axis** Evidence for interaction interface
- **Claim pointer** The authors claim that the carboxy-terminal end of C14orf166 binds to the carboxy-terminal of PA, with an intense interaction region at PA amino acids 610-630.
- **Evidence pointer** Abstract, results section; location not provided
- **Concern** The abstract states that PA residues from 450 to 700 are distributed in the interaction area, but the intense region is claimed to be 610-630. No quantitative data are provided to support this distinction, such as contact frequencies, buried surface area calculations, or energy contributions per residue. The basis for identifying 610-630 as "intense" is unclear.
- **Why it matters** The specific claim about the 610-630 region is the most concrete finding of the study. If this is not supported by robust computational metrics, the conclusion is speculative and could mislead subsequent experimental efforts.
- **Resolution test** Provide per-residue contact maps, buried surface area profiles, or interaction energy calculations that quantitatively demonstrate the enrichment of contacts in the 610-630 region relative to other PA segments. Show that this result is reproducible across different docking poses or parameter settings.

- **Concern ID** R1-M3
- **Severity** Major
- **Blocking** Yes
- **Axis** Experimental support for Y2H findings
- **Claim pointer** The authors claim that C14orf166 protein fragments in different sizes were found to interact with PA in a Y2H assay.
- **Evidence pointer** Abstract, methods description; location not provided
- **Concern** The abstract does not report the number of positive clones, the fragment sizes identified, the reproducibility of the interaction across replicates, or the results of control experiments (e.g., autoactivation tests, specificity against unrelated baits). Without these details, the Y2H result cannot be evaluated for false positives or technical artifacts.
- **Why it matters** Y2H screens are prone to false positives, and the absence of controls or quantitative reporting weakens the foundation of the entire study. If the Y2H interaction is not robust, the subsequent modeling efforts are built on an unreliable premise.
- **Resolution test** Report the number of independent clones per fragment, the results of autoactivation and specificity controls, and the statistical significance of the interaction signal. If possible, confirm the interaction with an orthogonal assay such as co-immunoprecipitation.

### Minor Comments

- **Concern ID** R1-m1
- **Severity** Minor
- **Axis** Clarity of terminology
- **Affected element** Introduction of C14orf166 function
- **Evidence pointer** Abstract, first sentence; location not provided
- **Issue** The phrase "RNA transcription, translation, and transport factor" is vague and not a standard descriptor. The subsequent sentences clarify some functions, but the initial characterization could be more precise.
- **Required correction** Replace with a more specific functional description, such as "a component of the tRNA-splicing ligase complex involved in RNA metabolism and nucleo-cytoplasmic transport."

- **Concern ID** R1-m2
- **Severity** Minor
- **Axis** Completeness of methods description
- **Affected element** Y2H screening details
- **Evidence pointer** Abstract, methods description; location not provided
- **Issue** The abstract mentions "HEK293 Matchmaker cDNA" but does not specify the library type, the bait construct details, or the selection conditions.
- **Required correction** Provide the full library name, the PA bait region used, and the growth selection markers or reporter genes employed.

- **Concern ID** R1-m3
- **Severity** Minor
- **Axis** Interpretation of docking results
- **Affected element** Conclusion on interaction model
- **Evidence pointer** Abstract, results section; location not provided
- **Issue** The abstract states that the carboxy-terminal end of C14orf166 is involved in the interaction, but it does not specify which C14orf166 residues or domains are implicated. This limits the utility of the model for designing follow-up experiments.
- **Required correction** Report the specific C14orf166 residue range or structural domain that contacts PA, based on the docking analysis.

## Risk / unsupported claims
- The claim that the carboxy-terminal end of C14orf166 binds to the carboxy-terminal of PA is unsupported by quantitative docking data in the abstract.
- The claim that the intense interaction region is at PA amino acids 610-630 is unsupported without per-residue interaction metrics.
- The claim that C14orf166 fragments interact with PA in Y2H is not evaluable without clone counts, controls, or reproducibility data.
- The overall interaction model is not assessable for reliability without model quality scores and docking statistics.
- The biological significance of the predicted interaction for viral replication is stated as background but not experimentally addressed in the abstract.